The topic:

Pycnogenol®, French maritime pine bark extract, is new to the joint health space but already has impressive clinical research studies showing promising joint health capabilities. As a powerhouse botanical ingredient, Pycnogenol® was found to promote joint mobility and flexibility, lower inflammatory marker C-reactive protein (CRP) while patients supplementing with Pycnogenol® consistently needed less NSAIDs. Join us to learn more about the research and the ingredient’s synergies in joint health formulations.

Speaker

Dr. Frank Schönlau
Scientific Director
Horphag Research

Frank Schönlau PhD, is the Scientific Director for Horphag Research. He is a biochemist and accomplished researcher having authored numerous published clinical studies on Pycnogenol® during his tenure with Horphag Research. He is considered to be one of the foremost industry experts on Pycnogenol® and his realm of expertise includes vascular diseases, chronic inflammation, autoimmune diseases and diabetic retinopathy.

Dr. Schönlau graduated from the University of Munster, Germany with a degree in chemistry and subsequently earned a PhD in biochemistry.